Presentation is loading. Please wait.

Presentation is loading. Please wait.

John Hanlon MSc MD FRCPC Michael Gofeld MD FIPP. Background  Intrathecal pump drug refill can result in significant adverse events  Real-time ultrasound-guided.

Similar presentations


Presentation on theme: "John Hanlon MSc MD FRCPC Michael Gofeld MD FIPP. Background  Intrathecal pump drug refill can result in significant adverse events  Real-time ultrasound-guided."— Presentation transcript:

1 John Hanlon MSc MD FRCPC Michael Gofeld MD FIPP

2 Background  Intrathecal pump drug refill can result in significant adverse events  Real-time ultrasound-guided pump access is a simple technique that may prevent such complications  The feasibility of teaching ultrasound-guided pump access to individuals with limited experience accessing intrathecal pumps is unknown

3 Study Design We evaluated the feasibility of ultrasound-guided intrathecal pump refill among seven novice trainees using unembalmed cadavers from the University of Washington Willed Body Program Prior to the study phase, each participant received a five minute teaching session on blind and ultrasound- guided pump access

4 Methods  Twenty random order pump access procedures performed by each subject:  10 blind, 10 ultrasound-guided  Low frequency ultrasound probe (MTurbo, SonoSite) and Medtronic pump refill kit were used  Performance videotaped for:  total procedure time  time from needle insertion to the port accessed  Success or failure determined by an expert faculty member  Participants questioned about their procedural confidence at time of study and three months later

5 Results – Table 1 Fellows (n= 7) Mean age (range)33 (32-35) Male (%)5 (71%) Residency completed Anesthesia PMR 6 (86%) 1 (14%) Prior Ultrasound experience (# of procedures) 0-25 26-50 >50 0 (0%) 1 (14%) 6 (86%) Comfort with Ultrasound based procedures Not at all Somewhat Very comfortable 0 (0%) 4 (43%) 3 (57%) Number of Intrathecal pump refills performed 0-10 >10 6 (86%) 1 (14%)

6 p < 0.01

7 p < 0.05

8 Results: Pocket fill and Confidence Number of unrecognized access failures (needle in subcutaneous tissue at procedure completion): Ultrasound-guided: 1/70 (1.4%) Blind: 3/70 (4.3%) Greater confidence in ability to access an intrathecal pump using a blind vs. ultrasound-guided approach? Ultrasound-guided: 7/7 (100%) Blind: 0/7 (0%)

9 Three Month Follow-Up Fellows (n=7) Mean number of “blind” pump accesses? (range) I feel confident with this method 1 (0-4) 7 (100%) Mean number of “US-guided” pump accesses? (range) I feel confident with this method 0 (0) 7 (100%) What would be your approach to refilling an intrathecal pump in a morbidly obese pt? Blind Ultrasound-guided Examine patient first to decide 0 (0%) 5 (71%) 2 (29%)

10 Limitations Pre-clinical pilot study Small number of participants Cadaver model Procedural time as an endpoint Measurement Needle passes and “patient comfort” unmeasurable Economy of motion (path length / movements) not measured Participant Bias

11 Conclusions Ultrasound-guided pump access is a simple technique that can be easily taught to trainees While the overall procedure takes longer than a blind approach, it is still efficient and may result in improved patient comfort due to decreased time from needle insertion to port access It is possible that Ultrasound-guided pump access may result in decreased inadvertent “pocket fills” Confidence in the utility of ultrasound-guided pump access is retained at three months even in the absence of ongoing experience

12 Acknowledgements University of Washington Willed Body Program Participants


Download ppt "John Hanlon MSc MD FRCPC Michael Gofeld MD FIPP. Background  Intrathecal pump drug refill can result in significant adverse events  Real-time ultrasound-guided."

Similar presentations


Ads by Google